This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Seattle Genetics Inc (SGEN)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 336.80M 286.76M 269.26M 210.81M
Cost of Sales 37.44M 16.72M 10.65M 4.74M
Gross Operating Profit 299.36M 270.04M 258.62M 206.08M
Selling, General, and Administrative Expenses 125.78M 104.32M 92.35M 84.30M
Research & Development 294.53M 230.74M 218.63M 170.30M
Operating Income before D & A (EBITDA) -120.95M -65.02M -52.36M -48.52M
Depreciation & Amortization n.a. 12.34M 10.50M 8.73M
Interest Income n.a. 0.00 0.00 0.00
Other Income - Net 464.00K 1.22M 341.00K 3.47M
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -120.49M -76.14M -62.52M -53.78M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -120.49M -76.14M -62.52M -53.78M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -120.49M -76.14M -62.52M -53.78M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -120.49M -76.14M -62.52M -53.78M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -120.49M -76.14M -62.52M -53.78M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -76.14M -62.52M -53.78M
Preferred Dividends
Net Income Available To Common 0.00 -76.14M -62.52M -53.78M
Basic EPS from Continuing Ops. -0.93 -0.62 -0.51 -0.46
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.93 -0.62 -0.51 -0.46
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.93 -0.62 -0.51 -0.46
Basic Normalized Net Income/Share n.a. -0.62 -0.51 -0.46
EPS fr Continuing Ops. -0.93 -0.62 -0.51 -0.46
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.93 -0.62 -0.51 -0.46
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.93 -0.62 -0.51 -0.46
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -0.62 -0.51 -0.46
Dividends Paid per Share 0.00 0.00 0.00 0.00
SGEN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SGEN Seattle Genetics Inc

Chart of SGEN

Analysts Ratings for SGEN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 3 3 3
Moderate Buy 1 1 1 1
Hold 4 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SGEN ANALYST REPORT

SGEN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs